Adverse event [GxP / QC / QA]

posted by kiranActimus – India, 2009-08-14 12:14 (6156 d 20:42 ago) – Posting: # 4048
Views: 7,182

Dear Bhavesh

According to ICH GCP Any untoward medical occurrence in a patient or clinical investigation subject administered a pharmaceutical product and which does not necessarily have a causal relationship with this treatment. An adverse event (AE) can therefore be any unfavourable and unintended sign (including an abnormal laboratory finding), symptom, or disease temporally associated with the use of a medicinal (investigational) product, whether or not related to the medicinal (investigational) product.

May be as u said the abnormality in the lab investigations is not because of the drug concentration we shall treat it as an adverse event only.

There are so many reasons for the change in the lab investigations other than the drug effect. It may be due to changes in the dietary habits etc.,

From the available literature of the past studies we can predict the possible side effects. If the abnormalities in the lab investigations are observed in the past studies we can say it is due to drug otherwise we need to investigate the cause of the abnormalities.

Thanks&regards
KK

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,570 registered users;
124 visitors (0 registered, 124 guests [including 22 identified bots]).
Forum time: 08:57 CEST (Europe/Vienna)

Competence, like truth, beauty and contact lenses,
is in the eye of the beholder.    Laurence J. Peter

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5